Kaleido Biosciences Inc. (KLDO) Reports In-Line Q1 EPS

Kaleido Biosciences Inc. (NASDAQ: KLDO) reported Q1 EPS of ($0.64), in-line with the analyst estimate of ($0.64).

For earnings history and earnings-related data on Kaleido Biosciences Inc. (KLDO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Reading (RDI) Tops Q2 EPS by 4c